Dishman Carbogen Amcis Ltd. benchmarking: Performance to industry peers

Financial

	Dishman Carbogen Amc	Zenotech Laboratorie	Jeevan Scientific
Operational Metrics
Pharmaceuticals
US DMF Filings	18.0 .	n/a	n/a
Total reactor capacity	1150.0 kL	n/a	n/a
R&D as a % of Total Sales	1.64 %	n/a	n/a
Financials
5 yr Average ROE	0.08 %	12.1 %	11.56 %
5yr average Equity Multiplier	1.61	1.13	1.54
5yr Average Asset Turnover Ratio	0.26	0.36	0.67
5yr Avg Net Profit Margin	-2.96 %	-13.89 %	6.3 %
Price to Book	0.43	2.98	3.56
P/E	23.24	0.0	0.0
5yr Avg Cash Conversion Cycle	24.66 Days	-1217.81 Days	-134.98 Days
Inventory Days	110.18 Days	145.01 Days	12.33 Days
Days Receivable	77.38 Days	61.38 Days	110.0 Days
Days Payable	156.95 Days	477.06 Days	504.46 Days
5yr Average Interest Coverage Ratio	0.4	-4.03	4.93
5yr Avg ROCE	0.91 %	9.71 %	13.74 %
5yr Avg Operating Profit Margin	13.93 %	5.56 %	18.71 %
5 yr average Debt to Equity	0.3	0.04	0.24
5yr CAGR Net Profit	n/a	n/a	-60.01 %
5yr Average Return on Assets	-0.73 %	8.4 %	5.42 %
Shareholdings
Promoter Holding	59.32 %	68.84 %	30.25 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	-8.19 %
Change in Mutual Fund Holding (3 Yrs)	-1.26 %	0.0	0.0

Business

	Dishman Carbogen Amc	Zenotech Laboratorie	Jeevan Scientific
Product Wise Break-Up	Product Wise Break-Up Contract Research & Contract Manufacturing (CRAMS) 68.3 Cholesterol & Vit D Analogues 16.9 API 11.2 Quats & Generics 3.6 Marketable Molecules 0 Lease rental income 0 Sale of Oncology Products 0 0 Clinical Research Services- Export 0 Clinical Research Services- Domestic 0 0 IT Consultancy Service Charges - Export 0	Product Wise Break-Up Clinical Research Services- Domestic 0 API 0 Marketable Molecules 0 Quats & Generics 0 Services- Contract Manufacturing 90.54 0 Cholesterol & Vit D Analogues 0 Sale of Oncology Products 0 IT Consultancy Service Charges - Export 0 Lease rental 9.46 Clinical Research Services- Export 0 0	Product Wise Break-Up CRO - Domestic 77.44 API 0 Marketable Molecules 0 Quats & Generics 0 0 0 Cholesterol & Vit D Analogues 0 Sale of Oncology Products 0 IT Consultancy Service Charges - Export 0 Lease rental income 0 CRO 22.56 0
Segment Break-Up	Segment Break-Up Carbogen Amcis 60.07 Others 39.93	-	-
Location Wise Break-Up	Location Wise Break-Up Rest of the World 98.29 India 1.71 Domestic 0	-	Location Wise Break-Up India 77.44 India 0 Rest of the World 0 Others 22.56
Operating Profit Break-Up	Operating Profit Break-Up Information Technology Services 0 Clinical Research services 0 Others 100	-	Operating Profit Break-Up CRO 100.0 Information Technology Services 0
Therapeutic Area Break-Up	Therapeutic Area Break-Up Non-APIs / Intermediates 31.68 Oncology 20.79 Ophthalmology 17.82 Hormones 13.86 Pain Management 3.96 Blood Related 3.96 Antibiotics 3.96 ADC-Warhead / ADC 3.96 Others 0.01	-	-

Dishman Carbogen Amcis Ltd.

Dishman Carbogen Amcis Ltd.

Financial

Business

SIGN UP FOR FREE